What is it about?
Medicine delivered to tissues must pass through cell membranes, but some tumors contain a mixture of different cell types that absorb drugs at vastly different rates. Most mathematical models of pharmacokinetic drug delivery assume a tumor is entirely uniform, effectively ignoring this biological mixture. This study upgrades a standard mathematical framework—the three-compartment model—to track what happens when a drug like doxorubicin is injected into a tumor containing two distinct cell types: one that easily absorbs the drug, and one that resists it. By simulating this heterogeneous environment, we can mathematically evaluate how the different cell populations interact and compete for the available medication.
Featured Image
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Why is it important?
We discovered that the composition of the cell types actively influences overall drug uptake in the tissue. When a tumor is mostly composed of drug-permeable cells, those cells rapidly consume the medicine and deplete it from the surrounding extracellular space. This rapid consumption leaves significantly less medication available for neighboring drug-resistant cells, as well as for any cells located further away from the blood vessel. Understanding this compounding depletion effect is critical, as it proves that the mere presence of permeable cells negatively influences the drug metabolism of the less permeable cells.
Perspectives
Collaborating on this project with Sid, Dan, Filippo, and Giuseppe was an incredibly rewarding experience because it allowed us to bridge the gap between abstract mathematical modeling and real-world clinical challenges. I have always been fascinated by how microscale cellular behaviors can disrupt even the most carefully calculated medical treatments. I truly hope this work encourages cancer researchers and pharmacologists to stop viewing tumors as uniform targets. By recognizing the complex, competitive environments inside living tissues, we can design smarter, more effective drug delivery systems that don't just treat the easiest cells, but conquer the resistant ones too.
Andrey V Kuznetsov
North Carolina State University
Read the Original
This page is a summary of: Model of drug delivery to populations composed of two cell types, Journal of Theoretical Biology, February 2022, Elsevier,
DOI: 10.1016/j.jtbi.2021.110947.
You can read the full text:
Contributors
The following have contributed to this page
